• About us
• Contact

Advertisement

Organisation › Details

OpGen Inc. (Nasdaq: OPGN)

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. Our molecular diagnostics and informatics products, product candidates and services combine our Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with our proprietary, curated MDRO knowledgebase. We are working to deliver our products and services, some in development, to a global network of customers and partners. The Acuitas AMR Gene Panel (RUO) is intended for Research Use Only and is not for use in diagnostic procedures. The Acuitas Lighthouse Software is not distributed commercially for antibiotic resistance prediction and is not for use in diagnostic procedures. For more information, please visit www.opgen.com. *

 

	Start	2001-01-01 established
	Group	OpGen (Group)
	Industry	Acuitas Lighthouse® AMR knowledgebase software
	Person	Dec, Timothy C. (OpGen 201909 CFO)
	Region	Madison, WI
	Country	United States (USA)
	Street	708 Quince Orchard Road
	City	20878 Gaithersburg, MD
	Tel	+1-301-869-9683
		Address record changed: 2020-12-02
Basic data	Employees	B: 11 to 50 (2018-12-31)
	Currency	USD
	Annual sales	2,946,307 (revenues, total, consolidated (2018) 2018-12-31)
	Profit	-13,368,098 (2018-12-31)
	Cash	4,572,487 (2018-12-31)
		* Document for »About Section«: Curetis N.V.. (9/4/19). "Press Release: Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses". Gaithersburg, MD, Amsterdam & Holzgerlingen.
		Record changed: 2021-04-21

Advertisement

More documents for OpGen (Group)

• [1] OpGen, Inc.. (3/25/24). "Press Release: OpGen Announces Acquisition of Preferred Stock by David Lazar". Rockville, MD....
• [2] OpGen, Inc.. (11/7/23). "FORM 8-K: OpGen’s Wholly Owned Subsidiaries Curetis GmbH and Ares Genetics GmbH Filed for Bankruptcy Protection"....
• [3] OpGen, Inc.. (12/9/20). "Press Release: OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics". Gaithersburg, MD & Vienna....
• [4] OpGen, Inc.. (11/24/20). "Press Release: OpGen, Inc. Announces $10 Million Private Placement Priced at the Market". Gaithersburg, MD....
• [5] OpGen, Inc.. (10/28/20). "Press Release: OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators". Gaithersburg, MD & Holzgerlingen....
• [6] Sphingotec GmbH. (4/16/20). "Press Release: SphingoTec Expands Leadership Team and Appoints Achim Plum as Managing Director and Chief Commercial Officer". Hennigsdorf....
• [7] Curetis N.V.. (1/14/20). "Press Release: Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S.". Amsterdam, Holzgerlingen & San Diego, CA....
• [8] OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD....
• [9] Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen....
• [10] OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.